Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Total article views   HTML views PDF downloads Totals
7,574 Dovepress* 7,151+ 1,071 8,222
PubMed Central* 423 120 543
Totals 7,574 1,191 8,765
*Since 5 September 2018

View citations on PubMed and Google Scholar